Skip to main content
Clinical Trials/NCT04005378
NCT04005378
Recruiting
Phase 4

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Northwell Health2 sites in 1 country300 target enrollmentJuly 1, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
First Episode Psychosis
Sponsor
Northwell Health
Enrollment
300
Locations
2
Primary Endpoint
Disengagement rate
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.

Detailed Description

In Phase 1 of the project, we will confirm a model predicting factors associated with later disengagement from CSC treatment. In Phase 2, we will compare disengagement among high-risk individuals with a CSC Step-down intervention to that with standard CSC care. The Step-down intervention will use web-based telemedicine and a smartphone app, to decrease disengagement likelihood. High-risk participants identified by predictors found in Phase 1 will be offered the intervention.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
May 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Enrolled into a CSC program

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Disengagement rate

Time Frame: Minimum of 6 months

Rate of disengagement from CSC program

Study Sites (2)

Loading locations...

Similar Trials